Special Edition VGR: COVID-19 Vaccine Update

Content Type: presentation

Presenter: Speakers: Freddy Caldera, DO, MS, Francis A. Farraye, MD, MSc, MACG, David T. Rubin, MD, FACG, Pascale M. White, MD; Moderator: David A. Greenwald, MD, FACG

Presenter Disclosure: Freddy Caldera, DO, MS: Dr. Caldera, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose; Francis A. Farraye, MD, MSc, MACG: Inflammatory Bowel Disease Advisory Boards for Pfizer; Research Grant: Mayo Clinic Florida; Royalties: Jones and Bartlett; Stockholder: Innovation Pharmaceuticals; David A. Greenwald, MD, FACG: Dr. Greenwald, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose; David T. Rubin, MD, FACG: Consultant and/or Grant Support: AbbVie, Altrubio, Arena Pharmaceuticals, Athos Therapeutics, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Ltd., Bristol-Myers Squibb, Celgene Corp/Syneos, GalenPharma/Atlantica, Genentech/Roche, Gilead Sciences, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Materia Prima, Pfizer, Prometheus Laboratories, Reistone, Takeda, Techlab, Inc.; Pascale M. White, MD: Dr. White, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

Event: ACG 2021 Virtual Grand Rounds

Release Date: 4/2/2021

Expiration Date: 4/2/2024

Objective: Explain the data behind the various vaccines, clinical recommendations, allergy and safety recommendation, and describe COVID -19 vaccine special issues in underrepresented minorities.